NCT01121172

Brief Summary

The aim of this study is to investigate serum apelin levels as well as their possible association with G212A polymorphism of the apelin receptor in obese children and adolescents. So far apelin has been reported to be involved in the pathophysiology of various heart diseases such as cardiomyopathies and heart failure. According to recent reports in adults apelin seems to be associated with impaired glucose metabolism, particularly in newly diagnosed diabetes type 2 patients. Obesity is associated with insulin resistance and compensatory hyperinsulinemia leading to diabetes mellitus type 2 even in youngsters. The researchers will try to investigate the role of this new adipokine in order to early detect and to prevent similar entities in childhood obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

May 4, 2010

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 12, 2010

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

May 19, 2016

Completed
Last Updated

May 19, 2016

Status Verified

April 1, 2016

Enrollment Period

2.1 years

First QC Date

May 4, 2010

Results QC Date

March 15, 2016

Last Update Submit

April 13, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Serum Apelin Levels

    Apelin levels were measured in serum of participants, in fasting state

    First day after enrollment and after 8-hours of night fasting, at approximately 8:00 pm in the morning

Secondary Outcomes (1)

  • Frequency of G212A Polymorphism of Apelin Receptor in Obese Children and Adolescents

    First day after enrollment

Study Arms (2)

obese

obese subjects according to International Obesity Task Force criteria

lean

Eligibility Criteria

Age2 Years - 16 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

40 obese children 40 obese adolescents 50 lean children 50 lean adolescents

You may qualify if:

  • Obese children and adolescents (aged 2-16 years old)

You may not qualify if:

  • Chronic diseases
  • Hypothyroidism
  • Medication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unit of Pediatric Endocrinology, Diabetes and Metabolism-4th Department of Pediatrics, Medical School of Aristotle University of Thessaloniki

Thessaloniki, 56403, Greece

Location

MeSH Terms

Conditions

ObesityInsulin ResistanceDiabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesDiabetes MellitusEndocrine System Diseases

Results Point of Contact

Title
Assimina Galli-Tsinopoulou, As.Professor of Pediatric Endocrinology
Organization
4th Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
As. Professor in Pediatric Endocrinology

Study Record Dates

First Submitted

May 4, 2010

First Posted

May 12, 2010

Study Start

May 1, 2010

Primary Completion

June 1, 2012

Study Completion

January 1, 2014

Last Updated

May 19, 2016

Results First Posted

May 19, 2016

Record last verified: 2016-04

Locations